| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Cancer Research, Vol 1, Issue 8 907-912, Copyright © 1995 by American Association for Cancer Research
ARTICLES |
H Ozcelik, S Mousses and IL Andrulis
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and Departments of Cellular and Molecular Pathology, Toronto, Ontario M5G 1X5, Canada.
Recently, several groups have isolated a cell cycle inhibitor gene (CIP1/WAF1) that is highly induced by wild-type, but not mutant forms of the p53 tumor suppressor. To test the hypothesis that p53 regulates CIP1/WAF1 expression in vivo, we evaluated CIP1/WAF1 mRNA expression levels in breast carcinomas from individuals with axillary node-negative disease with and without p53 mutations using quantitative reverse transcription-PCR. The data demonstrate that there is a strong negative correlation between the presence of p53 mutations and CIP1/WAF1 expression, suggesting that p53 mutations may reduce its ability to induce CIP1/WAF1 in vivo. In this study we observed tumors with low levels of CIP1/WAF1 mRNA in which there were no detectable p53 mutations. Determination of the CIP1/WAF1 levels in such specimens may provide a complementary strategy for analyzing the effects of p53 defects and/or may suggest the presence of alterations (such as coding mutations outside the conserved regions, promoter mutations, etc.) that may be missed by standard techniques.
This article has been cited by other articles:
|
|
 |
|
  C.-S. Wang, T.-L. Wu, K.-C. Tsao, and C.-F. Sun Serum TIMP-1 in Gastric Cancer Patients: A Potential Prognostic Biomarker. Ann. Clin. Lab. Sci., December 1, 2006; 36(1): 23 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Moriyama, S. Nishiguchi, A. Tamori, N. Koh, Y. Yano, S. Kubo, K. Hirohashi, and S. Otani Tumor-Suppressor Effect of Interferon Regulatory Factor-1 in Human Hepatocellular Carcinoma Clin. Cancer Res., May 1, 2001; 7(5): 1293 - 1298. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. Levesque, D. Katsaros, M. Massobrio, F. Genta, H. Yu, G. Richiardi, S. Fracchioli, A. Durando, R. Arisio, and E. P. Diamandis Evidence for a Dose-Response Effect between p53 (but not p21WAF1/Cip1) Protein Concentrations, Survival, and Responsiveness in Patients with Epithelial Ovarian Cancer Treated with Platinum-based Chemotherapy Clin. Cancer Res., August 1, 2000; 6(8): 3260 - 3270. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Chen, L. He, V. H. Savell, J. J. Jenkins, and D. M. Parham Inhibition of the Interferon-{{gamma}}/Signal Transducers and Activators of Transcription (STAT) Pathway by Hypermethylation at a STAT-binding Site in the p21WAF1 Promoter Region Cancer Res., June 1, 2000; 60(12): 3290 - 3298. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
